Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: sites default files styles large public images events Orange Ribbon png
Including Carer Utility Values in HTAs The Inclusion of the Utility Values for Carers and Family Members in HTAs: a Case Study of Recent NICE Appraisals in the UK Basarir H, Brockbank J, Knight C, Wolowacz S. Transcript: Caring for a family member or …
Assigning Treatment Strategy Using Real-World Data A Challenge of Real World Data: How to Assign Individuals to a Treatment Strategy When Their Data Are Consistent With Several Treatment Strategies at Baseline Garcia-Albeniz X , Hsu J, Hernan MA …
HTA and Reimbursement Considerations for Orphan Drugs in European Markets HTA and Reimbursement Considerations for Rare Diseases in European Markets: What Are the Implications for Manufacturers? Heyes A, McBride D, Pearson I, Copley-Merriman C …
… CGMA, is the Operations Director for Europe at RTI-HS. A large proportion of Ms. Walker's 20-year career was spent in …
… Operations at RTI-HS. Ms. Falvey has experience managing large, complex portfolios and projects with multiple tasks …
… a Marketing Specialist with RTI-HS. Ms. Howze’s focus is events, project managements, and content creation. She has a …
Services You must make critical decisions in today’s complex, competitive, and highly regulated pharmaceutical, medical device, and diagnostics industry. However, often, the knowledge needed to make good clinical, market access, and safety decisions isn’t …
… She has experience in secondary statistical analyses of large databases, as well as in designing and executing …
… access and medical affairs functions across both small and large pharmaceutical and medical device companies. She is …
Differences and Similarities of Health Economic Evaluation for Medical Technologies by HTA Bodies Vijay D'Souza, PhD Senior Associate, Market Access and Outcomes Strategy Transcript In recent years, an increasing number of medical technologies such as …